Adeka Corporation
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Analyst Recommendations 6 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Vanguard International Stock Index-Total Intl Stock Indx
|
1.4M | +1.03% | |
|
Tweedy Browne Global Value Fund
|
892.0K | 0.00% | |
|
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund
|
809.0K | +1.81% | |
|
iShares Core MSCI EAFE ETF
|
621.8K | 0.00% | |
|
DFA Japanese Small Company Series
|
494.5K | 0.00% | |
|
DFA International Core Equity Portfolio
|
402.6K | -1.23% |
Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥60 | -42.3% |
| 2025 | ¥104 | +6.1% |
| 2024 | ¥98 | +30.7% |
| 2023 | ¥75 | -2.6% |
| 2022 | ¥77 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥361,234M | ¥403,343M | ¥399,770M | ¥407,145M |
| Gross Profit | ¥95,212M | ¥98,218M | ¥104,691M | ¥114,865M |
| Operating Income | ¥34,032M | ¥32,370M | ¥35,429M | ¥41,010M |
| Pretax Income | ¥37,769M | ¥31,662M | ¥39,405M | ¥42,359M |
| Net Income | ¥23,687M | ¥16,778M | ¥22,977M | ¥25,019M |
| EPS | ¥229.65 | ¥163.30 | ¥224.87 | ¥245.55 |
| Operating Margin | 9.42% | 8.03% | 8.86% | 10.07% |
| Balance Sheet | ||||
| Total Assets | ¥475,304M | ¥500,068M | ¥543,057M | ¥543,118M |
| Total Equity | ¥249,968M | ¥260,949M | ¥285,142M | ¥296,690M |
| Total Liabilities | ¥225,336M | ¥239,119M | ¥257,915M | ¥246,428M |
| Cash | ¥84,249M | ¥81,119M | ¥98,429M | ¥110,117M |
| Interest-bearing Debt | ¥56,057M | ¥56,853M | ¥76,035M | ¥64,037M |
| Equity Ratio | 52.59% | 52.18% | 52.51% | 54.63% |
| D/E Ratio | 0.22 | 0.22 | 0.27 | 0.22 |
| Cash Flow | ||||
| Operating CF | ¥21,072M | ¥17,253M | ¥41,954M | ¥46,235M |
| Investing CF | -¥11,330M | -¥19,520M | -¥23,069M | -¥12,553M |
| Financing CF | -¥11,804M | -¥2,618M | -¥4,559M | -¥22,288M |
| Free CF | ¥7,500M | -¥603M | ¥20,203M | ¥30,008M |
| Efficiency | ||||
| ROE | 9.48% | 6.43% | 8.06% | 8.43% |
| ROA | 4.98% | 3.36% | 4.23% | 4.61% |
Latest IR Information
-
ADEKA CORPORATION (4401) 2027 Fiscal Year Q1 Financial Summary
For the first quarter of the 2027 fiscal year, net sales were 117,043 million yen, up year-on-year with profit growth. Operating income was 15,690 million yen, ordinary income was 16,620 million yen, and net income attributable to owners of the...
Read more -
Q1 FY2027 Consolidated Financial Results Supplementary Materials
For FY2026 Q1 cumulative, revenue 117.0 billion yen, up 15.2% YoY. Operating income 15.6 billion yen, up more than 37% YoY. By segment, chemicals, resin additives, and semiconductor materials saw substantial increases; food and others were weak or slight declines....
Read more -
Notice Regarding the Revision of Consolidated Earnings Forecast for the Second Quarter (Interim) and Full Year for the Fiscal Year Ending March 2027, and Revision of Dividend Forecast
We have upwardly revised the consolidated earnings forecast for the second quarter and full year of the fiscal year ending March 2027. Revenue is forecast at over 22,200 million yen for the second quarter and over 46,200 million yen for...
Read more -
[Adekawa] Completion of Share Buyback|2026-07-17
Adekawa Corporation completed the share buyback on June 19, 2026, with a total amount of ¥295,332,300. The shares repurchased were 71,700 common shares at ¥4,119 per share.
Read more -
[Takeda Pharmaceutical] Summary of Share Buyback and Incentive System | June 2026
Takeda Pharmaceutical plans to dispose of 71,700 shares of common stock at 4,119 JPY per share on July 17, 2026. This is part of an incentive system granted to directors, with a transfer restriction period of more than 3 years....
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥4,732
Rating Score: 1.83 (Based on 6 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Adeka Corporation engages in chemicals, food, and life sciences businesses. The company offers polymer additives, such as antioxidants, UV absorbers/hindered amine light stabilizers, nucleating agents/clarifying agents, metal deactivators/additives for filled polymers, flame retardants, epoxy type stabilizers/processability improvers/lubricants/water dispersion type stabilizers; plasticizers/PVC stabilizers; and photo/thermal curing materials, initiators, polymer materials, resist materials, thermal paper materials, semiconductor materials, circuit formation, and resin materials. Its chemical products also include water borne, epoxy, low chlorine epoxy, and urethane resins; epoxy resin adhesive; surface specialties, such as general-purpose and functional surfactants, functional cosmetic ingredients, lubricant additives, and base materials for lubricants; propylene glycol, peroxygen chemicals, metal soaps, ethanol preparation, and inorganic chemicals; and inducing joint filler and sealing materials, as well as civil engineering and construction materials. The company provides its chemical products to electronics and IT, plastics and rubber, personal care, industrial, liquid crystal display, automotive, and building and construction industries, as well as paints, coatings, and adhesives industries. In addition, it offers food products, such as margarines, shortening, fats and oils for chocolate, frying and cooking oil, whipped cream, cream for kneading, fillings, mayonnaise, and others. Further, the company engages in the plant design, construction management, equipment maintenance, logistics, warehousing, vehicle leasing, real estate, insurance agency services. The company was formerly known as Asahi Denka Co., Ltd. and changed its name to Adeka Corporation in May 2006. Adeka Corporation was incorporated in 1917 and is headquartered in Arakawa, Japan.